AIM AIM ImmunoTech Inc
Company Analysis
Latest News
🔴 AIM is trading 6.8% down today amidst ongoing negative sentiment from recent dilutive financing
AIM is trading 6.8% down at $0.28, driven by continued investor reaction to recent dilutive financing activities. • This includes at-the-market offerings and...
🔴 AIM is trading 6.6% down today after financing dilution and prior listing-compliance pressure
AIM is trading at $0.29 (-6.57%) as financing dilution and listing compliance risks continue to weigh on the stock. • Recent pressure is tied to the company’s...
🔴 AIM makes sharp 10.9% drop
AIM is trading at $0.32, down 10.9% versus the comparison close of $0.36 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 AIM is trading 7% down today on dilutive financing and bankruptcy risk warnings
AIM is trading 7% down at $0.33 as investors react to disclosures regarding highly dilutive financings and explicit liquidity and bankruptcy risk warnings. •...
🔴 AIM Plunges 5.2% as Investors React to Looming Dilutive Financings and Bankruptcy Risk
• AIM ImmunoTech Inc. is seeking stockholder approval for highly dilutive financings and a potential reverse stock split due to disclosed liquidity strain. •...
🔴 AIM is trading 6.4% down today on mixed reaction to clinical and investor updates
AIM is trading at $0.34 (6.4% down) today following mixed market reactions to recent clinical and corporate developments. • The company announced the...
🔴 AIM is trading 5.6% down today amid a broader market risk-off tone
AIM is trading 5.6% down at $0.36 as the stock faces pressure from a broader market risk-off sentiment and general weakness in speculative assets. • The move...
AIM ImmunoTech files 13.1M share resale, enabling early investor exits
AIM ImmunoTech filed an SEC prospectus for the resale of up to 13,077,089 common stock shares. Selling stockholders will offer these shares, meaning the...
🔴 AIM ImmunoTech Inc is trading 87% down today after highly dilutive NYSE-compliance financing
AIM ImmunoTech Inc is trading 86.5% down today at $0.37 following a sharp decline triggered by a heavily dilutive equity and warrant financing package. • The...
🔴 AIM ImmunoTech Inc is trading 5.1% down today, extending selloff after dilutive financing for NYSE compliance
AIM ImmunoTech Inc is trading at $0.38 (5.1% down) in pre-market, extending a sharp selloff triggered by a major capital restructuring aimed at maintaining its...
🔴 AIM ImmunoTech Inc is trading 86.2% down today on heavily dilutive financing and NYSE compliance restructuring
AIM ImmunoTech Inc is trading 86.2% down at $0.38 as investors react to a heavily dilutive financing and compliance-driven restructuring of its capital...
🔴 AIM ImmunoTech Inc is trading 5.1% down today as dilution-driven selloff continues
AIM ImmunoTech Inc is trading 5.1% down at $0.39 in pre-market, extending heavy losses following a sharp dilution-driven collapse. • The company recently...
🔴 AIM ImmunoTech Inc is trading 85% down today on heavy dilution from equity issuances used to regain NYSE compliance
AIM ImmunoTech Inc is trading 85% down today at $0.41 as investors react to significant shareholder dilution following recent equity and warrant issuances. •...
AIM ImmunoTech Regains Compliance with NYSE American Listing Standards
AIM ImmunoTech announced it has regained compliance with the NYSE American's continued listing standards after resolving a stockholder equity deficiency. The...
🔴 AIM ImmunoTech Inc is trading 84.27% down today after regaining NYSE American compliance and disclosing new financing
AIM ImmunoTech Inc is trading at $0.43 (-84.27%) after regaining NYSE American compliance with stockholders’ equity requirements. • The exchange removed the...
🟢 AIM ImmunoTech Inc is trading 14.6% up today after regaining NYSE American compliance
AIM ImmunoTech Inc is trading 14.6% up at $0.47 in pre-market sessions. • The company announced today, June 15, 2026, that it has regained compliance with NYSE...
🔴 AIM ImmunoTech Inc makes sharp 11.5% drop
AIM is trading at $0.41, down 11.5% versus the comparison close of $0.46 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 AIM ImmunoTech Inc is trading 85% down today after failing to resolve NYSE American equity-deficiency issues
AIM ImmunoTech Inc is trading 85% down at $0.42 after failing to resolve NYSE American equity-deficiency issues by the June 11, 2026, compliance deadline. •...
AIM ImmunoTech Risks NYSE Delisting, Faces Equity Compliance Deadline
AIM ImmunoTech Inc. faces a June 11, 2026, deadline to regain compliance with NYSE American listing standards. The company must resolve specific deficiencies...
AIM ImmunoTech Announces $1.3 Million Registered Direct Offering and Private Placement
AIM ImmunoTech Inc. entered into a securities purchase agreement with institutional investors for a registered direct offering and a concurrent private...